Structural modification induced in heparin by a fenton-type depolymerization process

Seminars in Thrombosis and Hemostasis

Volumn 33, Issue 5, 2007, Pages 466-477

  Vismara, Elena ^a   Pierini, Monica ^a   Guglieri, Sara ^b   Liverani, Lino ^c   Mascellani, Giuseppe ^c   Torri, Giangiacomo ^b  

^a POLITECNICO DI MILANO   (Italy)

^b Istituto di Ricerche Chimiche e Biochimiche G Ronzoni   (Italy)

^c Opocrin SpA   (Italy)

Author keywords

Fenton type reagent; Low molecular weight heparin (LMWH); Nuclear magnetic resonance; Radical depolymerization

Indexed keywords

ANTITHROMBIN; GLUCOSAMINE; HEPARIN; IDURONIC ACID; LOW MOLECULAR WEIGHT HEPARIN; URONIC ACID;

CELL HETEROGENEITY; CHEMICAL BINDING; CHEMICAL MODIFICATION; CONFERENCE PAPER; DEPOLYMERIZATION; DRUG STRUCTURE; HUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; REACTION ANALYSIS; SULFATION;

FREE RADICALS; HEPARIN, LOW-MOLECULAR-WEIGHT; IDURONIC ACID; MOLECULAR STRUCTURE; OXIDATION-REDUCTION;

EID: 34547125575     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-982077     Document Type: Conference Paper

References (37)

1. Casu B. Structure in biological activities of heparin. Adv Carbohydr Chem Biochem 1985;43:51-134
2. Venkataraman G, Shriver Z, Raman R, Sasisekharan R. Sequencing complex polysaccharides. Science 1999;286:537-542
3. Guerrini M, Raman R, Venkataraman G, Torri G, Sasisekharan R, Casu B. A Novel computational approach to integrate nmr spectroscopy and capillary electrophoresis for structure assignment of heparin oligosaccharides. Glycobiology 2002;12:713-719
4. Ferro DR, Ragazzi M, Provasoli A, et al. Conformers population of 1-iduronic acid residues in glycosaminoglycans sequences. Carbohydr Res 1990;195:157-167
5. Hricovini M, Guerrini M, Bisio A, Torri G, Petitou M, Casu B. Conformation of heparin pentasaccharide bound to antithrombin III. Biochem J 2001;359:265-272
6. Jacobsson I, Lindahl U, Jensen JW, Roden L, Prihar H, Feingold DS. Biosynthesis of heparin. Substrate specificity of heparosan N-sulfate D-glucuronosyl 5-epimerase. J Biol Chem 1984;259:1056-1063
7. Capila I, Linhardt RJ. Heparin-protein interaction. Angew Chem Int Ed 2002;41:390-412
8. Maccarana M, Casu B, Lindahl U. Minimal sequence in heparin/heparan sulfate required for binding of basic fibroblast growth factor. J Biol Chem 1993;268:23898-23905
9. Casu B, Lindahl U. Structure and biological interactions of heparin and heparan sulfate. Adv Carbohydr Chem Biochem 2001;57:159-208
10. Turnbull JE, Fernig DG, Ke Y, Wilkinson MC, Gallagher JT. Identification of the basic fibroblast growth factor binding sequence in fibroblast heparan sulfate. J Biol Chem 1992;267:10337-10341
11. Kreuger J, Salmivirta M, Sturiale L, Gimenez-Gallego GG, Lindahl U. Sequence analysis of heparan sulfate epitopes with graded affinities for fibroblast growth factors 1 and 2. J Biol Chem 2001;276:30744-30752
12. Ornitz DM, Herr AB, Nilsson M, Westman J, Svahn CM, Wachsman G. FGF binding and FGF receptor activation by synthetic heparan-derived di- and trisaccharides. Science 1995;268:432-436
13. Kowenski J, Duchaussoy F, Bono M, et al. A synthetic heparan sulfate pentasaccharide, exclusively containing - iduronic acid, displays higher affinity for FGF-2 than its - glucuronic acid-containing isomers. Bioorg Med Chem 1999;7:1567-1580
14. Guerrini M, Agulles T, Bisio A, et al. Minimal heparin/heparan sulfate sequences for binding to fibroblast growth factor-1. Biochem Biophys Res Commun 2002;292:222-230
15. Naggi A, Casu B, Perez M, et al. Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol splitting. J Biol Chem 2005;280(13):12103-12113
16. Casu B. Structure and active domains of heparin. In: Garg H, Linhardt R, Hales C, eds. Chemistry and Biology of Heparin and Heparan Sulfate. Boston, MA: Elsevier Science & Technology; 2005:1-19
17. Casu B, Lindahl U. Structure and biological interactions of heparin and heparan sulfate. Adv Carbohydr Chem Biochem 2001;57:159-208
18. Petitou M, Casu B, Lindahl U. 1976-1983, a critical period in the history of heparin: the discovery of the antithrombin binding site. Biochimie 2003;85:83-89
19. Iacomini M, Casu B, Guerrini M, Naggi A, Pirola A, Torri G. "Linkage region" sequences of heparins and heparan sulfates: detection and quantification by nuclear magnetic resonance spectroscopy. Anal Biochem 1999;274:50-58
20. Bisio A, De Ambrosi L, Gonella S, et al. Preserving the original heparin structure of a novel low molecular weight heparin by γ-irradiation. Arzneim Forschung 2001;51(II):806-813
21. Pejler G, Danielsson A, Bjork I, Lindahl U, Nader HB, Dietrich CP. Structure and antithrombin binding properties of heparin isolated from the clams Anomalocardia brasiliana and Tivela macroides. J Biol Chem 1987;262:11413-11421
22. Casu B, Guerrini M, Naggi A, Paterno M, Attolini M, Valle MG, et al. Characterization of sulfation patterns of beef and pig mucosal heparins by nuclear magnetic resonance spectroscopy. Arzneimittelforshung 1996;46:472-477
23. Bianchini P, Liverani L, Mascellani G, Parma B. Heterogeneity of unfractionated heparins studied in connection with species, source, and production processes. Semin Thromb Hemost 1997;23:3-10
24. Maccarana M, Sakura Y, Tawada A, Yoshida K, Lindahl U. Domain structure of heparan sulfates from bovine organs. J Biol Chem 1996;271(30):17804-17810
25. Casu B, Torri G. Structural characterization of low molecular weight heparins. Semin Thromb Hemost 1999;25:17-25
26. Linhardt JR, Gunay NS. Production and chemical processing of low molecular weight heparins. Semin Thromb Hemost 1999;25(suppl 3):5-16
27. Bisio A, Guglieri S, Frigerio M, et al. Controlled γ-ray irradiation of heparin generates oligosaccharides enriched in highly sulfated sequences. Carbohydr Polymers 2004;55:101-112
28. Guerrini M, Guglieri S, Beccati D, Torri G, Viskov C, Mourier P. Conformational transitions induced in heparin octasaccharides by binding with antithrombin III. Biochem J 2006;399:191-198
29. Edwards JO, Curci R. Fenton type activation and chemistry of hydroxyl radical. In: Strukul G ed. Catalytic Oxidations with Hydrogen Peroxide as Oxidant. London: Kluwer Academic; 1992:97-153
30. Casu B, Guerrini M, Torri G, Gonella S, Boveri G. Differentiation of beef and pig mucosal heparins by NMR spectroscopy. Thromb Haemost 1995;74:1205
31. Casu B, Torri G. Structural characterization of low-molecular weight heparins. Semin Thromb Hemost 1999;25(suppl 3):17-25
32. Torri G. New NMR methods for the structural characterization of glycosaminoglycans. In: Harenberg J, Casu B eds. Nonanticoagulant Glycosaminoglycans. New York: Plenum Press; 1996:15-25
33. 1H and C nuclear magnetic resonance spectroscopy for characterization of heparin preparations. Semin Thromb Hemost 2001;27:473-482
34. Guerrini M, Naggi A, Guglieri S, Santarsiero R, Torri G. Complex glycosaminoglycans: profiling substitution patterns by two-dimensional nuclear magnetic resonance spectroscopy. Anal Biochem 2005;337:35-47
35. Bertini S, Bisio A, Torri G, Bensi D, Terbojevich M. Molecular weight determination of heparin and dermatan sulfate by size exclusion chromatography with a triple detector array. Biomacromolecules 2005;6:168-173
36. 13C NMR spectral assignments of the major sequences of twelve systematically modified heparin derivatives. Carbohydr Res 1996;294:15-27
37. Nonhebel DC, Walton JC. Oxidations and reductions. In: Free-Radical Chemistry, Structure and Mechanism. Cambridge, UK: Cambridge University Press; 1974:404-405